When data from women who developed MF/MC breast cancer were analysed in isolation, the prevalence of oestrogen receptor positivity was 85% amongst BRCA2 mutation carriers but only 15% in BRCA1 mutation carriers. The gene discussed is BRCA1; the disease is breast cancer.